DE69407607T2 - Imidanolon- und oxanolonderivate als dopaminantagonisten - Google Patents

Imidanolon- und oxanolonderivate als dopaminantagonisten

Info

Publication number
DE69407607T2
DE69407607T2 DE69407607T DE69407607T DE69407607T2 DE 69407607 T2 DE69407607 T2 DE 69407607T2 DE 69407607 T DE69407607 T DE 69407607T DE 69407607 T DE69407607 T DE 69407607T DE 69407607 T2 DE69407607 T2 DE 69407607T2
Authority
DE
Germany
Prior art keywords
pct
image
date mar
derivatives
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69407607T
Other languages
English (en)
Other versions
DE69407607D1 (de
Inventor
William Carling
Kevin Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939319126A external-priority patent/GB9319126D0/en
Priority claimed from GB9407032A external-priority patent/GB9407032D0/en
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Publication of DE69407607D1 publication Critical patent/DE69407607D1/de
Application granted granted Critical
Publication of DE69407607T2 publication Critical patent/DE69407607T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE69407607T 1993-09-15 1994-09-06 Imidanolon- und oxanolonderivate als dopaminantagonisten Expired - Fee Related DE69407607T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939319126A GB9319126D0 (en) 1993-09-15 1993-09-15 Therapeutic agents
GB9407032A GB9407032D0 (en) 1994-04-08 1994-04-08 Therapeutic agents
PCT/GB1994/001934 WO1995007904A1 (en) 1993-09-15 1994-09-06 Imidazolone and oxazolone derivatives as dopamine antagonists

Publications (2)

Publication Number Publication Date
DE69407607D1 DE69407607D1 (de) 1998-02-05
DE69407607T2 true DE69407607T2 (de) 1998-08-06

Family

ID=26303524

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69407607T Expired - Fee Related DE69407607T2 (de) 1993-09-15 1994-09-06 Imidanolon- und oxanolonderivate als dopaminantagonisten

Country Status (9)

Country Link
US (1) US5698573A (de)
EP (1) EP0719264B1 (de)
JP (1) JPH09504272A (de)
AT (1) ATE161533T1 (de)
AU (1) AU682889B2 (de)
CA (1) CA2168740A1 (de)
DE (1) DE69407607T2 (de)
ES (1) ES2111326T3 (de)
WO (1) WO1995007904A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3916093B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 光学活性イミダゾリジノン誘導体とその製造方法
IL114027A (en) * 1994-06-08 1999-11-30 Lundbeck & Co As H 4-Phenyl piperazine (piperidine or tetrahydropyridine) derivatives serotinin 5-HT1A and dopamin D2 receptor ligand pharmaceutical compositions containing them
GB9500580D0 (en) * 1995-01-12 1995-03-01 Merck Sharp & Dohme Therapeutic agents
AU740064B2 (en) * 1997-06-18 2001-10-25 H. Lundbeck A/S Heterocyclic substituted piperidines and uses thereof
US6159990A (en) 1997-06-18 2000-12-12 Synaptic Pharmaceutical Corporation Oxazolidinones as α1A receptor antagonists
US6228870B1 (en) 1998-11-10 2001-05-08 Merck & Co., Inc. Oxazolidinones useful as alpha 1a adrenoceptor antagonists
US6319932B1 (en) 1998-11-10 2001-11-20 Merck & Co., Inc. Oxazolidinones useful as alpha 1A adrenoceptor antagonists
EP3929192A1 (de) 2020-06-23 2021-12-29 Université de Franche-Comté Verbindungen zur behandlung von neurodegenerativen erkrankungen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3355457A (en) * 1965-05-21 1967-11-28 American Cyanamid Co Substituted 2-imidazolinones
NL130094C (de) * 1966-06-13 1900-01-01
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法
IT1230703B (it) * 1989-01-26 1991-10-29 Luso Farmaco Inst Derivati imidazolonici ad attivita' antiipertensiva, loro metodi di preparazione e composizioni farmaceutiche che li contengono.
JP3916093B2 (ja) * 1993-09-17 2007-05-16 杏林製薬株式会社 光学活性イミダゾリジノン誘導体とその製造方法

Also Published As

Publication number Publication date
CA2168740A1 (en) 1995-03-23
DE69407607D1 (de) 1998-02-05
AU682889B2 (en) 1997-10-23
US5698573A (en) 1997-12-16
JPH09504272A (ja) 1997-04-28
AU7542494A (en) 1995-04-03
EP0719264A1 (de) 1996-07-03
EP0719264B1 (de) 1997-12-29
WO1995007904A1 (en) 1995-03-23
ES2111326T3 (es) 1998-03-01
ATE161533T1 (de) 1998-01-15

Similar Documents

Publication Publication Date Title
ATE182139T1 (de) Dopamin rezeptor subtyp liganden
DE69223989D1 (en) Azyklische ethylendiaminderivate als 'substance p rezeptor' antagonisten
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
DE69032020D1 (de) N-Substituierte 4-Pyrimidinamine und -Pyrimidindiamine, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
NZ504336A (en) Tetrahydrofuran substituted adenosine A1 receptor agonists, pharmaceuticals thereof, and their use as medicaments
GR3026231T3 (en) 3-aminopiperidine derivatives and related nitrogen containing heterocycles.
YU41100A (sh) N-acil derivati cikličnih amina
DE69407607D1 (de) Imidanolon- und oxanolonderivate als dopaminantagonisten
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
GB9305641D0 (en) Therapeutic agents
ES2094840T3 (es) 1-(pirido(3,4-b)-1,4-oxazinil-4-il)-1h-indoles, compuestos intermedios y un procedimiento para su preparacion, y su uso como medicamentos.
WO1996005166A1 (fr) Derive d'amine substitue et composition medicamenteuse le contenant
DE69415341D1 (de) Kondensierte tricyclische heteroaromatische derivate als liganden des dopamin-rezeptor-subtyps
DE69407191D1 (de) Kondensierte tricyclische heteroaromatische verbindungen als dopamin-rezeptor-subtyp-liganden
DE69016531T2 (de) 2,3-Dihydro-1-(pyridinylamino)-indole, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel.
DE69431471D1 (de) Amide derivate als 5-ht1a liganden
ATE159943T1 (de) Heterozyclische amine mit zns-wirksamkeit
ES2173167T3 (es) Derivados de benzodiazepina.
MX9703671A (es) Compuesto de aminometil arilo y ligandos selectivos del subtipo de receptor de la dopamina.
DE3161640D1 (en) Propanol amine, derivatives, process for their preparation and medicines containing these compounds
ES2135383T3 (es) Pirido(3,4-b)pirrolo(1,2-e)(1,4,5)oxadiazepinas y compuestos analogos relacionados, un procedimiento para su preparacion y su uso como medicamentos.
ATE167873T1 (de) Neue heterocyclische acyldipeptide, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
TH11174EX (th) อนุพันธ์ของพิเพอดิลอกซิ-ไอซอกซาโซล,การเตรียมสารเหล่านั้นและการใช้ในการรักษา
TH35872A (th) อนุพันธ์ 1,4-ไดซับสทิทิวเทด พิเพอริดีนที่มีฟลูออรีน

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee